PRPH

ProPhase Labs Inc (PRPH)

Healthcare • NASDAQ • $0.01-2.20%

Key Fundamentals
Symbol
PRPH
Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research
Price
$0.01
Daily Change
-2.20%
Market Cap
$155925
Trailing P/E
N/A
Forward P/E
0.02
52W High
$5.40
52W Low
$0.01
Analyst Target
N/A
Dividend Yield
0.00%
Beta
0.14
About ProPhase Labs Inc

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammator…

Company website

Research PRPH on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...